Indication
Somatic Mutation
1 clinical trial
2 products
3 drugs
Clinical trial
Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological MalignanciesStatus: Recruiting, Estimated PCD: 2027-11-30
Drug
fludarabineProduct
BusulfanDrug
MelphalanDrug
VarlilumabProduct
Levetiracetam